At a time when most categories of equity funds are giving negative returns, technology funds (up 4.2 per cent on an average) and pharma funds (up 2.2 per cent) have managed to remain in the positive territory over the past few months. Investors, however, need to understand their prospects before deciding to raise their exposure to these export-oriented sectors.
India: Life market expected to grow by 15% in next 3-5 years
Read More
